Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H7ClN2O4S2 |
| Molecular Weight | 270.714 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NS(=O)(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O
InChI
InChIKey=NENBAISIHCWPKP-UHFFFAOYSA-N
InChI=1S/C6H7ClN2O4S2/c7-5-2-1-4(14(8,10)11)3-6(5)15(9,12)13/h1-3H,(H2,8,10,11)(H2,9,12,13)
| Molecular Formula | C6H7ClN2O4S2 |
| Molecular Weight | 270.714 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.drugs.com/uk/pdf/leaflet/725899.pdfCurator's Comment: Description was created based on several sources, including https://www.drugs.com/international/clofenamide.html and https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C77559
Sources: https://www.drugs.com/uk/pdf/leaflet/725899.pdf
Curator's Comment: Description was created based on several sources, including https://www.drugs.com/international/clofenamide.html and https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C77559
Clofenamide is a benzenedisulfonamide-based agent and carbonic anhydrase (CA) inhibitor with diuretic activity. Clofenamide inhibits CA, thereby preventing sodium, bicarbonate and thus water reabsorption in the proximal convoluted tubule resulting in diuresis.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2095180 Sources: http://www.genome.jp/dbget-bin/www_bget?D01822 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Aponiere Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| [X-ray structural analysis of kidney stones. Mechanism of action of pharmalith in nephrolithiasis]. | 1999-03-18 |
|
| Binding of 2-amino-4-chloro-m-benzenedisulfonamide as a metabolite of hydrochlorothiazide to erythrocytes. | 1990-10 |
|
| Biopharmaceutical studies of thiazide diuretics. III. In vivo formation of 2-amino-4-chloro-m-benzenedisulfonamide as a metabolite of hydrochlorothiazide in a patient. | 1987-08 |
|
| The influence of diuretics on the excretion and metabolism of doping agents. III. Etilamfetamine. | 1986-09 |
|
| Electron-capture GLC assay of dichlorphenamide. | 1979-03 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:30:40 GMT 2025
by
admin
on
Wed Apr 02 09:30:40 GMT 2025
|
| Record UNII |
582ILN204B
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
C03BA07
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
||
|
NCI_THESAURUS |
C448
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
||
|
WHO-ATC |
C03BB07
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
||
|
WHO-VATC |
QC03BA07
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
||
|
WHO-VATC |
QC03BB07
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL1865258
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | |||
|
SUB06697MIG
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | |||
|
C77559
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | |||
|
693
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | |||
|
DB13663
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | |||
|
671-95-4
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | |||
|
211-588-5
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | |||
|
1396
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | |||
|
582ILN204B
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | |||
|
100000084290
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | |||
|
69594
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | |||
|
CLOFENAMIDE
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | |||
|
DTXSID4046153
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | |||
|
m1078
Created by
admin on Wed Apr 02 09:30:41 GMT 2025 , Edited by admin on Wed Apr 02 09:30:41 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |